Cargando…
Sepsis, complement and the dysregulated inflammatory response
Sepsis in human beings is a major problem involving many individuals and with a high death rate. Except for a single drug (recombinant activated protein C) that has been approved for treatment of septic patients, supportive measures represent the main clinical approach. There are many models of expe...
Autores principales: | Ward, Peter A, Gao, Hongwei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087605/ https://www.ncbi.nlm.nih.gov/pubmed/19725914 http://dx.doi.org/10.1111/j.1582-4934.2009.00893.x |
Ejemplares similares
-
Manipulation of the Complement System for Benefit in Sepsis
por: Ward, Peter A., et al.
Publicado: (2012) -
Role of Complement and Histones in Sepsis
por: Zetoune, Firas S., et al.
Publicado: (2020) -
Diseases of complement dysregulation—an overview
por: Wong, Edwin K. S., et al.
Publicado: (2018) -
The eye as a complement dysregulation hotspot
por: Clark, Simon J., et al.
Publicado: (2017) -
Investigation of Association of Complement 5 Genetic Polymorphisms with Sepsis and Sepsis-Induced Inflammatory Responses
por: Chen, Kaidian, et al.
Publicado: (2021)